National and Kapodistrian University of Athens
Αξιολόγηση της παροχής υπηρεσίας κλινικής γενετικής στον τομέα των σπανίων δυσμορφικών συνδρόμων σε ενα ελληνικό τμήμα κλινικής γενετικής
Abstract
dc:descriptionDysmorphology concerns the recognition and management of rare, multiple anomaly syndromes. The objective of this study was an attempt to evaluate the clinical genetics service in the field of rare dysmorphic syndromes (Dysmorphology), in a Hellenic department of medical genetics. The first step in defining evaluation measures is to provide information on the impact of a service, to support its development. As there is no consensus, so far, on appropriate efficiency measures for Dysmorphology, we chose (A) to examine, according to the WHO distinction the impact of the service provided to: 1. individual patients/families suffering from a genetic disorder; 2. populations at increased risk of a genetic disorder and (B) to investigate and compare the nature and utility of a Dysmorphology service in three different conditions: two Mediterranean cities, Athens, Hellas and Afula, Israel (MDS), the Manchester Centre for Genomic Medicine, a UK service with dysmorphology expertise (UKDS) and the DYSCERNE, digital service (DDS).This study includes examples of individual Greek patients with extremely rare chromosomal syndromes diagnosed by Chromosomal microarray analysis as well as Greek populations with a dysmorphic syndrome caused by a founder mutation: in both categories, the Dysmorphology service had a specific impact on the definition and enrichment of the corresponding phenotypes, providing information associated with the prognosis of patients and assumptions on the underlying pathological mechanisms. Using the specific example of Cohen syndrome caused by a founder (mediterranean) mutation, Greek patients are at a higher risk of developing blindness in respect to those of other ethnicities and genotypes. The Greek/Mediterranean founder mutation is correlated to a phenotype characterized by specific and persistent skeletal features, corneal changes, periodontal disease, a distinct neurocognitive phenotype for the high recurrence of autism and non-verbal communication and inconstant microcephaly.This study also includes the results of the use of the DYSCERNE pilot project that was funded in 2007 by the European Commission Public Health Executive Agency (EU DG Sanco) aimed at setting up a network of expertise for patients with rare dysmorphic disorders. We report the outcome of this service for 200 cases submitted consecutively between January 2010 and 2012. We also show that it is more likely that Chromosome Microarray Analysis will be performed if suggested in the UKDS rather than in the MDS; this, most probably reflects the difference of access to genetic testing following funding limitations in the MDS. We also demonstrate that in terms of achieved diagnosis, the first visit to a dysmorphology clinic is more significant than a follow-up. We show that a confirmed syndrome diagnosis significantly decreases the requests for other, non genetic, laboratory investigations. Conversely, it increases the requests for reviews by other specialists and, most significantly, it increases further requests for screening for possible associated complications. This is the first demonstration of the demands, on a health service, following the diagnosis of a dysmorphic condition.We imagine the future genomic dysmorphology service as an interface between professionals in genetics that includes access to genetic counsellors but also bioin- formaticians, a piece of health infrastructure that may be a Clinical Centre for Genomic Medicine or a Health Data Repository, the findings themselves including the incidental ones, and, possibly, a revenue stream. This interface, unlike the classic genetic clinic could be an e-service or an e-business available on data clouds, to be used according to local demand. We believe it is important to remember that technologies will invariably progress, yet the final role of the dysmorphologist will always be to be mindful that at the centre of all this there is a patient with a rare, complex condition and their family but also patient groups as co-adjuvants of the design of health care policies
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Douzgou, Sofia
- Ντούζγου, Σοφία
Subjects
dc:subject × 6Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36353